Related Experiment Video

Updated: Aug 3, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
10:24

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins

Published on: September 28, 2012

Constitutively active DNA damage checkpoint pathways as the driving force for the high frequency of p53 mutations in

Thanos D Halazonetis1

  • 1Wistar Institute and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104-4268, USA. halazonetis@wistar.upnn.edu

DNA Repair
|July 29, 2004
PubMed

Insights

The p53 protein, a DNA damage checkpoint protein, is inactivated in human cancers because DNA damage checkpoint pathways are activated. This activation creates selective pressure for TP53 mutations during tumorigenesis.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • The p53 protein is a critical DNA damage checkpoint protein.
  • Inactivation of p53 is frequently observed in human cancers.
  • The selective pressure for TP53 mutations in tumors remains incompletely understood.

Purpose of the Study:

  • To hypothesize the link between p53 inactivation and its DNA damage checkpoint function in human cancer.
  • To explore the role of activated DNA damage checkpoint pathways in driving TP53 mutations.

Main Methods:

  • This study presents a theoretical argument based on existing biological principles.
  • It integrates knowledge of p53 function, DNA damage response, and cancer genetics.

Main Results:

  • The hypothesis posits that p53 inactivation in cancer is directly related to its checkpoint function.
  • Tumorigenic transformation is proposed to involve constitutive DNA double-strand breaks (DSBs) in each cell cycle.
  • Activated DNA DSB checkpoint pathways provide the selective pressure for p53 inactivation.

Conclusions:

  • The high frequency of p53 inactivation in human cancers is driven by the selective pressure exerted by activated DNA damage checkpoint pathways.
  • This perspective links the fundamental role of p53 in DNA repair to its frequent mutation in cancer development.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage10:59

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage

Published on: August 21, 2021

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...